Health – NRI Digital https://www.nridigital.com Mon, 01 Oct 2018 11:24:18 +0000 en-GB hourly 1 https://wordpress.org/?v=6.8.3 https://www.nridigital.com/wp-content/uploads/2017/08/NRI-favicon-retina-66x66.png Health – NRI Digital https://www.nridigital.com 32 32 Selling cells: the economics of CAR-T therapy https://www.nridigital.com/health/selling-cells-economics-car-t-therapy/ Tue, 23 Oct 2018 11:21:29 +0000 https://www.nridigital.com/?p=9532 As a new class of CAR-T cell therapies moves through clinical trials and the first of these innovative treatments enters the market, the therapy is causing almost as much consternation as excitement in the healthcare sphere. While CAR-T looks set to transform the treatment of cancer, what does the future hold for one of the [...]

The post Selling cells: the economics of CAR-T therapy appeared first on NRI Digital.

]]> As a new class of CAR-T cell therapies moves through clinical trials and the first of these innovative treatments enters the market, the therapy is causing almost as much consternation as excitement in the healthcare sphere. While CAR-T looks set to transform the treatment of cancer, what does the future hold for one of the industry’s most advanced – and expensive – treatments? Sally Turner finds out.

The post Selling cells: the economics of CAR-T therapy appeared first on NRI Digital.

]]> Using AI to personalise drug combination therapy https://www.nridigital.com/health/using-ai-personalise-drug-combination-therapy/ Tue, 16 Oct 2018 11:16:02 +0000 https://www.nridigital.com/?p=9529 Doctors routinely employ a combination therapy strategy for cancer patients, but figuring out which drugs to use is a challenge. Researchers at the National University of Singapore have developed an artificial intelligence platform called QPOP to streamline this process. Abi Millar finds out more about how the platform could personalise combination therapy.

The post Using AI to personalise drug combination therapy appeared first on NRI Digital.

]]> Doctors routinely employ a combination therapy strategy for cancer patients, but figuring out which drugs to use is a challenge. Researchers at the National University of Singapore have developed an artificial intelligence platform called QPOP to streamline this process. Abi Millar finds out more about how the platform could personalise combination therapy.

The post Using AI to personalise drug combination therapy appeared first on NRI Digital.

]]> Amazon and PillPack: an unstoppable pharmacy force? https://www.nridigital.com/health/amazon-pillpack-unstoppable-pharmacy-force/ Tue, 09 Oct 2018 11:11:47 +0000 https://www.nridigital.com/?p=9526 After months of speculation over Amazon’s ambitions in the healthcare space, news broke in June that the online retail juggernaut had bought PillPack, a US-based online pharmacy. The move rattled the US pharmacy market, which so far has remained sheltered from high street woes by the fact prescription drugs can’t be readily accessed online. But [...]

The post Amazon and PillPack: an unstoppable pharmacy force? appeared first on NRI Digital.

]]> After months of speculation over Amazon’s ambitions in the healthcare space, news broke in June that the online retail juggernaut had bought PillPack, a US-based online pharmacy. The move rattled the US pharmacy market, which so far has remained sheltered from high street woes by the fact prescription drugs can’t be readily accessed online. But is that set to change? Chris Lo investigates.

The post Amazon and PillPack: an unstoppable pharmacy force? appeared first on NRI Digital.

]]> Improving clinical trial transparency in the Americas https://www.nridigital.com/health/improving-clinical-trial-transparency-americas/ Tue, 02 Oct 2018 10:46:12 +0000 https://www.nridigital.com/?p=9523 A new paper published in the British Medical Journal by two University of Toronto researchers has provided an overview of clinical trial and health data transparency across the Americas. While real strides have been made, more progress is needed, especially as some countries still don’t impose registration of trials in a publicly accessible registry. Sally [...]

The post Improving clinical trial transparency in the Americas appeared first on NRI Digital.

]]> A new paper published in the British Medical Journal by two University of Toronto researchers has provided an overview of clinical trial and health data transparency across the Americas. While real strides have been made, more progress is needed, especially as some countries still don’t impose registration of trials in a publicly accessible registry. Sally Turner spoke to the report authors to find out more.

The post Improving clinical trial transparency in the Americas appeared first on NRI Digital.

]]> The $1bn project digging up soil to find new medicines https://www.nridigital.com/health/1bn-project-digging-soil-find-new-medicines/ Thu, 09 Aug 2018 14:00:40 +0000 https://www.nridigital.com/?p=8695 Genentech has signed a $1bn collaboration deal with Lodo Therapeutics to develop unique, natural products from the microbial DNA found in soil. With this level of investment confidence must be high, but just how much potential lies in soil, and how can it be harnessed? Sally Turner finds out in the new issue of Pharma [...]

The post The $1bn project digging up soil to find new medicines appeared first on NRI Digital.

]]> Genentech has signed a $1bn collaboration deal with Lodo Therapeutics to develop unique, natural products from the microbial DNA found in soil. With this level of investment confidence must be high, but just how much potential lies in soil, and how can it be harnessed? Sally Turner finds out in the new issue of Pharma Technology Focus.

 

The post The $1bn project digging up soil to find new medicines appeared first on NRI Digital.

]]> Will the FDA’s name and shame tactic help speed up generic drug developement? https://www.nridigital.com/health/will-fdas-name-shame-tactic-help-speed-generic-drug-developement/ Thu, 02 Aug 2018 13:55:09 +0000 https://www.nridigital.com/?p=8692 The US Food and Drug Administration has publicly listed the names of nearly 40 pharma companies that may have been denying access to reference samples for generic drug manufacturers, thereby delaying generic competition. Is this ‘name and shame’ strategy justified, and just how big is the issue of pharma companies holding back reference samples from [...]

The post Will the FDA’s name and shame tactic help speed up generic drug developement? appeared first on NRI Digital.

]]> The US Food and Drug Administration has publicly listed the names of nearly 40 pharma companies that may have been denying access to reference samples for generic drug manufacturers, thereby delaying generic competition. Is this ‘name and shame’ strategy justified, and just how big is the issue of pharma companies holding back reference samples from generic competitors after patent expiry? Chris Lo investigates in the latest issue of Pharma Technology Focus

The post Will the FDA’s name and shame tactic help speed up generic drug developement? appeared first on NRI Digital.

]]> US approval for Epidiolex fuels new hope for cannabinoid-based medicines https://www.nridigital.com/health/us-approval-epidiolex-fuels-new-hope-cannabinoid-based-medicines/ Thu, 26 Jul 2018 13:54:17 +0000 https://www.nridigital.com/?p=8690 In June the US Food and Drug Administration approved the country's first cannabinoid-based drug, Epidiolex, for treating seizures in two forms of severe epilepsy. Abi Millar asks what this milestone will mean for other cannabinoid-based medicines being developed in the country.

The post US approval for Epidiolex fuels new hope for cannabinoid-based medicines appeared first on NRI Digital.

]]> In June the US Food and Drug Administration approved the country’s first cannabinoid-based drug, Epidiolex, for treating seizures in two forms of severe epilepsy. Abi Millar asks what this milestone will mean for other cannabinoid-based medicines being developed in the country.

The post US approval for Epidiolex fuels new hope for cannabinoid-based medicines appeared first on NRI Digital.

]]> Virtual reality surgery: the healthcare potential of augmented reality https://www.nridigital.com/health/virtual-reality-surgery-healthcare-potential-augmented-reality/ Thu, 03 May 2018 13:17:46 +0000 https://www.nridigital.com/?p=7954 German company ApoQlar is developing the Virtual Surgery Intelligence software tool, which uses mixed reality to help surgeons prepare for and carry out surgery. We spoke to the developers about its potential applications in surgical procedures in the latest issue of Medical Technology.

The post Virtual reality surgery: the healthcare potential of augmented reality appeared first on NRI Digital.

]]> German company ApoQlar is developing the Virtual Surgery Intelligence software tool, which uses mixed reality to help surgeons prepare for and carry out surgery. We spoke to the developers about its potential applications in surgical procedures in the latest issue of Medical Technology.

The post Virtual reality surgery: the healthcare potential of augmented reality appeared first on NRI Digital.

]]>